Research progress on the molecular mechanism of coronary microvascular endothelial cell dysfunction

Jianying Deng1

  • 1Department of Cardiovascular Surgery, Chongqing Kanghua Zhonglian Cardiovascular Hospital, Chong Qing, China.

Insights

Coronary microvascular disease involves damage to coronary microvascular endothelial cells (CMECs). Understanding the molecular mechanisms of CMEC damage is crucial for diagnosing and treating this high-risk cardiovascular condition.

Area of Science:

  • Cardiovascular Science
  • Cell Biology
  • Pathophysiology

Background:

  • Coronary microvascular disease (CMD) is a significant risk factor for cardiovascular events.
  • CMD's pathophysiology is poorly understood due to its subtle presentation and diverse causes, hindering clinical management.
  • Damage to coronary microvascular endothelial cells (CMECs) is central to CMD development and progression.

Purpose of the Study:

  • To review the molecular mechanisms underlying coronary microvascular endothelial cell (CMEC) damage.
  • To elucidate the role of CMEC dysfunction in the early stages of coronary microvascular disease.

Main Methods:

  • Literature review of studies on coronary microvascular disease.
  • Analysis of molecular pathways involved in CMEC stress, metabolism, and inflammation.

Main Results:

  • CMEC stress, metabolic dysfunction, and inflammation are key features of early-stage CMD.
  • These cellular dysfunctions are causally linked to the development and progression of coronary microvascular disease.

Conclusions:

  • Understanding the molecular mechanisms of CMEC damage is essential for advancing the diagnosis and treatment of CMD.
  • Targeting CMEC dysfunction presents a potential therapeutic strategy for cardiovascular events related to CMD.